Mega schemes for pharma development, med-tech innovation and reducing dependency API import to be announced next month
The Hindu
The Minister said that six priority areas have been identified - new chemical entity; complex generics and biosimilars; precision medicines; medical devices; orphan drugs; and anti-microbial resistance.
The Ministry of Chemicals and Fertilizers will soon announce a ₹5,000-crore research programme aimed at reducing India’s import dependency on Active Pharmaceutical Ingredients (API) and promoting discovery of new drug molecules.
As part of the programme, the Ministry will also initiate strengthening of research infrastructure through Centres of Excellence (CoEs) in the seven existing National Institutes of Pharmaceutical Education and Research (NIPERs) at a tentative cost of ₹700 crore over a period of five years.
Speaking about the policy decision, Mansukh Mandaviya, Minister of Chemicals and Fertilizers, on Tuesday said that India will soon start a research registry which will be a one-stop site for all institutes, industry, and academics to know and possibly collaborate on research ideas and processes.
The Minister said that six priority areas have been identified - new chemical entity; complex generics and biosimilars; precision medicines; medical devices; orphan drugs; and anti-microbial resistance. They will see research and investment push in the next 10 years and an announcement in this regard will be done in the coming month.
“The policies aim to engage nine established pharmaceutical companies in impact research across six priority areas with prestigious government institutes. The government will financially support these projects with 35% of total cost - up to ₹125 crore over five years - following a milestone-based benefit-sharing approach,” said the Minister.
He added that around 125 research projects with commercial potential will be selected. Funding of up to ₹1 crore per project over five years, following benefit-sharing, will be provided from “ideation to proof of concept, facilitating innovation and growth”.
The Union Cabinet in July this year had approved the ‘National Policy on Research and Development and Innovation in the Pharma-MedTech Sector’. It also approved a new Scheme for Promotion of Research and Innovation in Pharma-MedTech sector (PRIP) with a total outlay of ₹5,000 crore for a period of five years, i.e., from 2023-24 to 2027-28.
The rupee falls 9 paise to a record low of 90.41 against the dollar amid trade deal uncertainties and foreign fund outflows.
Mercedes-Benz India will increase vehicle prices by up to 2% in January to counter rising costs and currency pressures.
CCI is investigating if IndiGo violated competition norms amid significant flight disruptions and concerns over its dominant market position.
The Coal Controller Organisation is appointed to regulate and register proposed coal exchanges, enhancing market competition and oversight.
The rupee hits a record low amid U.S. trade stalemate and portfolio outflows, prompting potential RBI intervention.
November 2025 sees robust growth in India's auto industry, with record sales in passenger vehicles, two-wheelers, and three-wheelers.
Stock markets soar as Sensex and Nifty extend gains in early trade, driven by positive global trends and U.S. rate cuts.
Petroleum and Natural Gas Rules 2025 amended to enhance business ease, extend lease durations, and strengthen domestic exploration infrastructure.
Tata Hitachi strengthens its focus on India's construction market amid global tariffs and rupee depreciation, leveraging local growth opportunities.
Domestic household savings replace foreign institutional money, giving Indian markets stability but raising concerns about unequal participation and limited returns for new retail investors. Access asymmetry and unequal outcomes emerge as key challenges, making investor protection, lower fees, passive investing, and stronger governance crucial.
The Ministry of Petroleum and Natural Gas (MoPNG) should work closely with the Ministry of External Affairs (MEA), and other concerned government agencies, to strengthen diplomatic engagement with oil-producing countries, secure favourable investment terms and address tax and regulatory hurdles faced by public-sector enterprises (PSEs) abroad, the parliamentary committee on public undertakings (2025-26) stated in their latest report tabled Wednesday.
Why is the rupee falling? Is it falling worse than other currencies? Does the fall hurt or help the Indian economy? And finally, is this a cause for alarm? Here we discuss these questions.
There’s great momentum in India in terms of AI and agentic AI applications getting deployed, observed Satya Nadella, Chairman and Chief Executive Officer, Microsoft.